BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is being made by the company to purchase gold bullion, for working capital, and general corporate purposes.
Joint book-running managers of the offering are Clear Street and Needham & Company.
Public Offering Announcement
BioSig Technologies, Inc. intends to offer shares of common stock through an underwritten public offering to purchase gold bullion and for general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Offering Details
The offering is pursuant to a shelf registration statement on Form S-3, declared effective by the SEC on December 17, 2024.
- BioSig Technologies intends to use the proceeds from the offering for strategic investments in gold bullion, working capital, and general corporate uses.
- The appointment of Clear Street and Needham & Company as joint book-running managers indicates a strong management team overseeing the offering.
BioSig Technologies' proposed public offering signifies a strategic move to raise capital for investment in gold bullion and support its corporate operations.